Stocks to buy

Cybersecurity technology company CrowdStrike (NASDAQ:CRWD) has given investors plenty to cheer about lately. CRWD stock has risen nearly 30% so far in 2021 and 78% over the past year.  Source: Shutterstock That kind of growth has led many investors to question whether a slowdown is imminent. The good news is that it doesn’t appear to

The markets are far from efficient right now, with several undervalued stocks that boast historically-stable cash flows, scandal-free operations, and a robust profitability profile, relegated to the background. Most of the column inches and headlines are reserved for hyper-growth stocks and exciting recovery plays. Post-pandemic, the outlook for several exceptional stocks remains pessimistic because of

At the end of last year, I wrote that analysts’ earnings projections for Moderna (NASDAQ:MRNA) were $9.46 per share for 2021. Now those same analysts have average earnings per share (EPS) forecasts of $30.12 for 2021, or over 3 times the prior numbers. I wrote that MRNA stock was worth $180. But as of Friday,

ViacomCBS (NASDAQ:VIAC) produced excellent growth for its Q2 results ending June 30, but free cash flow (FCF) was disappointing. Except for its growth in Q1 2021, the company said that its FCF was just $75 million, vs. $1.589 billion last quarter. Nevertheless, VIAC stock could be at least 23% higher next year if its FCF

The markets are entering the last quarter of another eventful year for equities as an asset class. Without doubt, the year will be remembered for Reddit and Meme stocks. It’s also a year when Robinhood (NASDAQ:HOOD) trading platform gained significant traction as millennials took a plunge into stock trading. In general, meme stocks were among

It’s no secret the investing world is obsessed with all-electric vehicles (EVs). Several EV stocks, Tesla (NASDAQ:TSLA) being chief among them, have given investors triple-digit gains this year. But in recent weeks, the stocks have seen a correction. Against this backdrop, QuantumScape (NYSE:QS) stock, down 12.5% last month, becomes an interesting play. Source: Michael Vi/Shutterstock.com

Cassava Sciences (NASDAQ:SAVA), the Alzheimer’s disease (AD) drug company, certainly has had a rough time. In fact, one author recently called SAVA stock a “volatile, battleground stock.” This is because the company has endured a number of short attacks recently. Most of these came out after their recent September release of 9-month Phase 2 results.

Nio (NYSE:NIO) stock is in a slump. It’s not anywhere near the extent of punishment it suffered in 2019 when NIO stock plummeted 85% in 8 months. However, NIO is down 29% from the end of June when it was trading just over the $53 mark. And it’s down about 30% since the start of the

Cinema stocks weren’t buzzworthy until 2021 when movie theater chain AMC Entertainment (NYSE:AMC) became a target of Reddit traders. Once they took hold of AMC stock, all bets were off and the share price soared. Source: QualityHD / Shutterstock.com Indeed, it wouldn’t be unreasonable to call 2021 the “Year of the Meme Stock.” Yet, will this wild

Prior to 2020, arguably the general political consensus was that former President Donald Trump would easily win reelection. Though he has always had rough edges that made him a polarizing figure, President Trump got things done. In turn, his no-nonsense approach to high-level negotiations represented a narrative boon for infrastructure stocks, what with the America

A pharmaceutical play, Novavax (NASDAQ:NVAX) has been on the move. In fact, NVAX stock has risen nearly three times higher since November of last year. Source: Ascannio/Shutterstock.com This leap is primarily due to the company’s Covid-19 vaccine inching closer to commercial release. However, despite the price appreciation, I believe there is still plenty of upside

The bull market on Wall Street has been going on for at least eight years. Late last week equities hit a small snag, and sellers stepped in early everyday and ruined a perfectly strong open. Even before Wednesday’s pop, they were still 2% away from the all time highs. Therefore, investors should be looking for

Sofi Technologies (NASDAQ:SOFI) has been incredibly volatile over the last few months. In May, SOFI stock bottomed along with most other high-growth stocks. That was as the group’s bear market came to an end.  Source: rafapress / Shutterstock.com Soon after, shares erupted, nearly hitting $25 and for a moment climbing more than 75% from the

Backed by billionaire Bill Ackman, Pershing Square Tontine (NYSE:PSTH) may have been one of the hottest special purpose acquisition companies (SPACs) earlier this year. However, after what played out last month, that’s certainly no longer the case. As fellow InvestorPlace contributor Ian Bezek recently wrote, this name’s deal to purchase a stake in Universal Music

Just because we hit retirement, doesn’t mean we’re making a total shift to bonds. There are still stocks to buy that are both interesting and profitable. But more times than not, investors at that stage are looking for some income. That involves a lot more than just screening dividend stocks and sorting by yield. Investors

Luminar (NASDAQ:LAZR) has fallen on tough times as of late, but LAZR stock will be shining in the lidar spotlight soon enough. Source: JHVEPhoto/shutterstock.com Luminar’s weakness in the near-term price action doesn’t make a whole lot of sense. For one, the near-term fundamental trends underlying the self-driving company are as strong as ever, making this

Rejection can be painful, especially if you’re a longtime investor in Canadian cannabis company Sundial Growers (NASDAQ:SNDL). Time and again, SNDL stock has flirted with the key $1 level, but gravity keeps pulling it back down. Source: Postmodern Studio / Shutterstock.com I’ll admit, I recommended a patient stance on Sundial Growers in July, and my timing wasn’t perfect.

Last week was one of the strangest ones I’ve seen in a long while. The mood on Wall Street soured tangibly without any significant evidence of deterioration in price. The indices were still within a half percent of an all-time high, yet the headlines read of corrections. The commentary sounded like we had already dropped

Novavax (NASDAQ:NVAX) released its second-quarter results on Aug. 5 and updated the market on its Covid-19 vaccine progress. Their Covid candidate has performed well in its Phase 3 trials and the company expects to apply for emergency use authorization (EUA) for distribution in the U.S. during Q4. As a result, it looks like NVAX stock

Roku (NASDAQ:ROKU) is still a growth stock, despite the fact that it’s been falling lately. In fact, in my last article on ROKU stock, I wrote that it could end up falling some 20% to 30% from Aug. 11. That was when it was at $369.21. Since then, it has fallen 9%. Source: Michael Vi